Latest Breaking News On - Heritage pharmaceuticals - Page 5 : comparemela.com

ADVERTISEMENT ADVERTISEMENT Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL Law360 (March 2, 2021, 6:53 PM EST) Mylan, Teva and Par Pharmaceuticals are among a group of generic-drug makers that told a Pennsylvania federal judge Monday they re fine with her plan to swap out a bellwether case in multidistrict litigation that accuses most of the generics industry of price-fixing. The companies told U.S. District Judge Cynthia M. Rufe they share her inclination for scrapping the planned bellwether trial in a case brought by various state attorneys general that centers around Teva. Instead, the companies want Judge Rufe to select another case one that focuses on Heritage Pharmaceuticals, which the court mentioned as a possibility less than a.

United statesCynthiam rufeHeritage pharmaceuticalsPar pharmaceuticalsJudge cynthiaJudge rufeஒன்றுபட்டது மாநிலங்களில்பாரம்பரியம் மருந்துகள்இணையானது மருந்துகள்நீதிபதி சிந்தியாநீதிபதி ரூஃப்